Compare diversification strategies and see how each ETF's unique index focus shapes risk and return for healthcare sector investors.

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the 'Company” or 'Zhengye”), a veterinary vaccine manufacturer that ...

Rick Bienkowski, Ph.D. and Caroline Palomeque have joined Ladenburg Thalmann’s Biotechnology Equity Research team as Managing Directors.

MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer ...

The structural advantages that allow China to conduct clinical trials more quickly and at lower costs should be leveraged to ...

Led by Boston/Cambridge in first place, the top four markets remained unchanged from the previous two years. Boston was ...

Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration—key factors ...

The Golden LEAF Foundation has provided $1.5 million to the Johnston County Industrial Development Corporation to expand and ...

Chief Minister DK Shivakumar will hold Finance, Cabinet Affairs, DPAR, Intelligence and other unallocated portfolios, while ...

An early trial of a vaccine made using the technology found it is safe and well-tolerated, with a larger study to include ...

Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting ...

MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA ...